Pay in 4 interest-free payments of $23.75 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
0 mg/kg Bortezomib treatment results in significant inhibition of human plasmacytoma xenograft growth
3)16-8-10-19(11-9-16)33(28
In the clonogenic assay
CAS Number: 620112-78-9
38(6):1260-5
Pentostatin Size:Solid 2 mg 0 mg/kg Bortezomib treatment resultsPentostatin is classified as a purine analog, which is a type of antimetabolite. It mimics the nucleoside adenosine and thus inhibits the enzyme adenosine deaminase, interfering with the cell's ability to process DNA. Cancer cells generally divide more often than healthy cells; DNA is highly involved in cell division (mitosis) and drugs which target DNA related processes are therefore more toxic to cancer cells than healthy cells. Pentostatin is used